title: Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS).
authors.affiliation: University of Western Ontario, London, Ontario, Canada. janet.pope@sjhc.london.on.ca.
authors.forename: Janet
authors.initials: J
authors.lastname: Pope
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards; D017281:Cost of Illness; D004417:Dyspnea / Q000175:diagnosis* / Q000453:epidemiology; D005767:Gastrointestinal Diseases / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000453:epidemiology; D015141:Los Angeles; D017060:Patient Satisfaction; D010819:Physician's Role; D011928:Raynaud Disease / Q000175:diagnosis* / Q000453:epidemiology; D012595:Scleroderma, Systemic / Q000175:diagnosis* / Q000453:epidemiology; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires / Q000592:standards*; D014495:Universities / Q000592:standards